Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | -15,516 | 11,234 | 10,358 | 11,115 | 9,601 |
| Operating Income | 15,516 | -11,234 | -10,358 | -11,115 | -9,591 |
| Other Income | -2,726 | 1,410 | 262 | 378 | 512 |
| Pre-tax Income | 12,789 | -9,824 | -10,095 | -10,737 | -9,079 |
| Net Income Continuous | 12,789 | -9,824 | -10,095 | -10,737 | -9,079 |
| Net Income | $12,789 | $-9,824 | $-10,095 | $-10,737 | $-9,079 |
| EPS Basic Total Ops | 24.72 | -15.00 | -16.00 | -17.00 | -14.00 |
| EPS Basic Continuous Ops | 24.27 | -15.24 | -15.66 | -16.66 | -13.94 |
| EPS Diluted Total Ops | 24.72 | -15.00 | -16.00 | -17.00 | -14.00 |
| EPS Diluted Continuous Ops | 24.27 | -15.24 | -15.66 | -16.66 | -13.94 |
| EPS Diluted Before Non-Recurring Items | -11.00 | -15.00 | -16.00 | N/A | N/A |
| EBITDA(a) | $15,516 | $-11,226 | $-10,345 | $-11,100 | $-9,578 |